BML Investment Partners L.P. 13D and 13G filings for Odonate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-28 3:36 pm Unchanged |
2022-01-19 | 13G | Odonate Therapeutics, Inc. ODTC |
BML Investment Partners L.P. | 0 7.400% |
0 (Unchanged) |
Filing |
| 2022-01-28 3:29 pm Purchase |
2022-01-28 | 13G | Odonate Therapeutics, Inc. ODTC |
BML Investment Partners L.P. | 0 7.400% |
0 (New Position) |
Filing |